Immunic, Inc. (IMUX)
NASDAQ: IMUX · Real-Time Price · USD
0.6790
-0.0329 (-4.62%)
At close: Dec 1, 2025, 4:00 PM EST
0.6804
+0.0014 (0.21%)
After-hours: Dec 1, 2025, 7:53 PM EST

Immunic Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
82906862251317
Upgrade
Market Cap Growth
-21.16%33.02%9.04%-75.28%-20.70%222.80%
Upgrade
Enterprise Value
48329-10142185
Upgrade
Last Close Price
0.711.001.501.409.5715.29
Upgrade
PB Ratio
6.694.892.340.551.982.00
Upgrade
P/TBV Ratio
7.804.892.340.552.672.52
Upgrade
Debt / Equity Ratio
0.080.050.050.010.010.01
Upgrade
Quick Ratio
1.171.641.999.107.8115.37
Upgrade
Current Ratio
1.311.772.129.639.2115.93
Upgrade
Return on Equity (ROE)
-398.50%-424.44%-131.28%-100.01%-65.02%-40.54%
Upgrade
Return on Assets (ROA)
-125.08%-128.79%-68.13%-40.53%-30.30%-26.18%
Upgrade
Return on Capital (ROIC)
-246.99%-246.62%-85.24%-44.44%-32.31%-28.00%
Upgrade
Return on Capital Employed (ROCE)
-993.20%-524.50%-335.60%-75.40%-58.30%-30.70%
Upgrade
Earnings Yield
-125.84%-111.58%-138.24%-193.89%-37.00%-13.89%
Upgrade
FCF Yield
-109.47%-94.39%-105.09%-105.08%-33.16%-14.61%
Upgrade
Buyback Yield / Dilution
-53.55%-126.03%-39.29%-34.52%-51.00%-102.84%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q